HomeCompareVTIAF vs MO

VTIAF vs MO: Dividend Comparison 2026

VTIAF yields 31.37% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MO wins by $54.5K in total portfolio value· pulled ahead in Year 6
10 years
VTIAF
VTIAF
● Live price
31.37%
Share price
$6.38
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.6K
Annual income
$3.98
Full VTIAF calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — VTIAF vs MO

📍 MO pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVTIAFMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VTIAF + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VTIAF pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VTIAF
Annual income on $10K today (after 15% tax)
$2,666.67/yr
After 10yr DRIP, annual income (after tax)
$3.38/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, MO beats the other by $25,631.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VTIAF + MO for your $10,000?

VTIAF: 50%MO: 50%
100% MO50/50100% VTIAF
Portfolio after 10yr
$52.8K
Annual income
$15,081.57/yr
Blended yield
28.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

VTIAF
No analyst data
Altman Z
0.3
Piotroski
6/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VTIAF buys
0
MO buys
0
No recent congressional trades found for VTIAF or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVTIAFMO
Forward yield31.37%6.36%
Annual dividend / share$2.00$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%22.6%
Portfolio after 10y$25.6K$80.1K
Annual income after 10y$3.98$30,159.17
Total dividends collected$3.4K$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: VTIAF vs MO ($10,000, DRIP)

YearVTIAF PortfolioVTIAF Income/yrMO PortfolioMO Income/yrGap
1$12,269$1,568.63$10,570$780.30+$1.7KVTIAF
2$14,027$899.29$11,381$1,032.90+$2.6KVTIAF
3$15,489$480.45$12,535$1,392.73+$3.0KVTIAF
4$16,821$247.92$14,193$1,920.91+$2.6KVTIAF
5$18,124$125.81$16,618$2,723.68+$1.5KVTIAF
6← crossover$19,457$63.35$20,263$3,993.80$806.00MO
7$20,850$31.78$25,936$6,098.36$5.1KMO
8$22,326$15.91$35,166$9,775.01$12.8KMO
9$23,896$7.96$51,026$16,597.78$27.1KMO
10$25,573$3.98$80,113$30,159.17$54.5KMO

VTIAF vs MO: Complete Analysis 2026

VTIAFStock

VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.

Full VTIAF Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this VTIAF vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VTIAF vs SCHDVTIAF vs JEPIVTIAF vs OVTIAF vs KOVTIAF vs MAINVTIAF vs PMVTIAF vs BTIVTIAF vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.